Granahan Investment Management LLC Purchases Shares of 91,020 HealthEquity, Inc. $HQY

Granahan Investment Management LLC purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 91,020 shares of the company’s stock, valued at approximately $8,338,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Acumen Wealth Advisors LLC bought a new stake in HealthEquity during the 4th quarter valued at $27,000. Caitong International Asset Management Co. Ltd grew its stake in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after acquiring an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd bought a new stake in shares of HealthEquity in the 4th quarter worth $28,000. Torren Management LLC bought a new stake in shares of HealthEquity in the 4th quarter worth $40,000. Finally, Northwestern Mutual Wealth Management Co. grew its stake in shares of HealthEquity by 190.4% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock worth $55,000 after acquiring an additional 396 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $85.66 on Wednesday. The company’s 50-day moving average is $84.71 and its 200 day moving average is $85.48. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The company has a market capitalization of $7.16 billion, a P/E ratio of 32.08, a price-to-earnings-growth ratio of 1.46 and a beta of 0.21. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $106.60.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities research analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on HQY. Citizens Jmp upped their target price on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research note on Monday, June 1st. Raymond James Financial set a $100.00 target price on shares of HealthEquity in a research note on Tuesday, February 17th. Barrington Research reiterated an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a research note on Friday, May 22nd. UBS Group set a $110.00 target price on shares of HealthEquity in a research note on Tuesday, February 17th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research note on Thursday, March 19th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $110.57.

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the transaction, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares in the company, valued at $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 13,081 shares of company stock valued at $1,193,000. 1.60% of the stock is owned by insiders.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.